This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
10 patients each would have provided an 80% power to detect a 20% difference in adherence rates. Sample size calculations were then performed retrospectively. These showed that the study had a 90% power to detect statistically significant differences in missed school, missed work, and office re-visits with the sample size used in the analysis.
The paediatricians were drawn from a pool of 375 paediatricians listed in the 1996 Fellowship Directory of the AAP. Those listed in Connecticut cities and towns within a 20-mile radius of New Haven, who anticipated seeing 20 eligible patients within the following year and who had equipment available in their offices, were screened for eligibility. Initially, 138 (80 residents, fellows; 58 academic) were found to be ineligible. Of the 237 remaining available, a further 22 were ineligible (mainly because they were not in active practice) and 18 declined. The paediatricians were then randomly selected. Of the final sample of 11 paediatricians, two dropped out (one moved out of state and one had an excessive workload). The remaining 9 paediatricians enrolled 10 consecutive patients each (one enrolled 11 children), resulting in a sample of 91 children in the control group. Subsequently, the same 9 paediatricians enrolled 74 consecutive patients (six enrolled 10 patients each, while three enrolled 8, 5 and 1 patient) for the intervention group. The mean age was 10.3 years in the control group (age range: 5 -17.4) and 10.8 years in the intervention group (age range: 5 -17.8).
Study design
This was a prospective comparative study with historical controls, which was conducted in several primary care centres. The patients were identified in two different timeframes. A random system based on number tables was used to select paediatricians from the 1996 Fellowship Directory of the AAP. The physicians and patients were blinded to the hypothesis of the study. The patients were followed for 7 to 14 days and one of the study authors contacted them by telephone. Seven patients in the control group and 6 patients in the intervention group were lost to follow-up. The physicians received $200 as partial compensation at the end of the study. Paediatricians were not constrained to follow the guidelines suggested by the computerised system.
Analysis of effectiveness
The analysis of effectiveness was limited to those patients who provided complete data. The outcomes used in the analysis were:
the adherence rate, defined as the proportion of visits at which the physicians performed an intervention following guideline recommendations; the number of PEFR measurements; the number of oxygen saturation measurements; the number of nebulisation treatments; and a series of immediate and intermediate outcomes, such as improved asthma severity after discharge, immediate disposition home or to the emergency department (ED)/direct hospitalisation, missed school or missed work days for caretakers at follow-up, and the number of office re-visits, ED visits, and hospitalisations at follow-up.
The authors did not comment on the comparability of the two groups, but stated that the intervention patients had a more severe disease than the control patients. Accordingly, a covariate analysis was performed, taking this potential confounding factor into consideration.
Effectiveness results
The average adherence rate was: 0.86 in the control group and 0.94 in the intervention group for PEFR assessment, (p=0.320); 0.29 (control) versus 0.56 (intervention) for oxygen saturation assessment, (p=0.007); The mean number of PEFR measurements was 1.6 (control) versus 2.2 (intervention), (p=0.001).
The mean number of oxygen saturation measurements was 0.48 (control) versus 1.1 (intervention), (p=0.017).
The average number of nebulisation treatments was 0.77 (control) versus 1.2 (intervention), (p=0.026).
In terms of immediate patient outcomes (from presentation to discharge), there was a reduction in severity of asthma symptoms for 43.3% of the control group patients versus 57.7% of the intervention group patients. This differences approached statistical significance, (p=0.069). However, differences in intermediate outcomes after 1-month follow-up (missed school or missed workdays for caretakers and number of office re-visits, ED visits and hospitalisations) did not reach statistical significance.
Physicians commented that they often disagreed with the recommendations made in the guidelines.
Clinical conclusions
The effectiveness study showed that the implementation of guidelines led to an increase in the number of assessments and office treatments. However, no beneficial effects in terms of immediate or intermediate outcome measures were observed.
Measure of benefits used in the economic analysis
The health outcomes were left disaggregated and no summary benefit measure was used in the economic analysis. In effect, a cost-consequences analysis was conducted.
Direct costs
Discounting was not relevant since the costs per patient were incurred during a short time. The unit costs were not presented separately from the quantities of resources used. The health services included in the economic evaluation were prescriptions, duration and number of visits, tests and treatments performed in the office. The cost/resource boundary of the study was unclear. The costs were based on total physician fees for the visit. Resource use was derived from actual individualised data, which referred to the sample of patients who were considered in the effectiveness study. Data forms were used and resource usage was estimated from 1996 to 1998, but the price year was not reported.
Statistical analysis of costs
The t-test was used to test the statistical significance of differences in the estimated fees. An analysis of covariance was conducted to assess the impact of potential confounding factors on the estimated charges.
The authors compared their findings with those from other studies and stated that similar results were observed in the literature. In terms of the generalisability of the study results to other settings, the authors noted that their sample of physicians was representative of paediatric practice in Connecticut. However, due to practice variations, the results of the analysis should not be extrapolated to settings with different epidemiologic characteristics or treatment patterns.
The study referred to children with asthma who presented with exacerbations and this was reflected in the authors' conclusions.
Implications of the study
The study results suggested that more research should be conducted before implementing guidelines for the management of asthmatic children. Physicians tended to resist some explicit recommendations, in particular the administration of oxygen therapy. Therefore, caution is required when implementing guidelines that have not yet been validated.
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